TA, B., C, D. P., CD, M., DM, C., L, A., WJG, O., . . . G, K. (2019). Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 60(3), 353. https://doi.org/10.2967/jnumed.118.216069
Chicago Style (17th ed.) CitationTA, Burley, Da Pieve C, Martins CD, Ciobota DM, Allott L, Oyen WJG, Harrington KJ, Smith G, and Kramer-Marek G. "Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 60, no. 3 (2019): 353. https://doi.org/10.2967/jnumed.118.216069.
MLA (9th ed.) CitationTA, Burley, et al. "Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 60, no. 3, 2019, p. 353, https://doi.org/10.2967/jnumed.118.216069.